Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

WDR5/KMT2A interaction inhibitors presented by OICR

Sep. 20, 2017

Roche divulges BACE1 inhibitors

Sep. 20, 2017

UCB discloses new plasmepsin V inhibitors for malaria treatment

Sep. 20, 2017

CSIR identifies novel aurone alkaloids for tuberculosis

Sep. 19, 2017

New serine protease HTRA1 inhibitors disclosed by Roche

Sep. 19, 2017

Galapagos presents new sphingosine 1-phosphate receptor antagonists

Sep. 19, 2017

Novel interleukin-1 receptor-associated kinase 4 inhibitors identified at Bayer

Sep. 19, 2017

Emcure Pharmaceuticals discovers novel IDO-1, TDO inhibitors

Sep. 19, 2017

Phoenix Molecular Designs synthesizes novel ribosomal s6 kinase inhibitors

Sep. 18, 2017

Shanghai Pharmaceuticals Holding identifies new EGFR/ERBB2 inhibitors

Sep. 18, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...